Tapewire
HeatmapsAnalyticsCompareCompaniesCountriesGovernment bodiesPeopleETFsSectorsIndustriesWatchlistPortfolioTerminalScreenerBrokersToolsLearnGlossaryMethodologyAPIPricing

CRESCENT BIOPHARMA, INC. — insider transactions

11 transactions on record · CBIO · CIK 1253689

Aggregates

computed from the filings below
Purchases, 12m
2
count of open-market buys
Sales, 12m
9
count of open-market sales
Buy / sell ratio, 12m
0.22
purchases per sale
Distinct insiders, 12m
8
Bought, 3m
$20M
Sold, 3m
$285.5K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$12.4M
2026-07-16
Director share, 12m
36.4%
of transactions where role is stated
Current run
9 sells
consecutive same-direction transactions
Net 3m flow
$19.7M
purchases minus sales
Total on record
11

Transactions

11 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-09-182026-09-162Bispham Barbara HarlinSee RemarksOpen market sale620$17.90$11.1Kfiling
2026-09-182026-09-162Brumm Joshua TDirector, Chief Executive OfficerOpen market sale1,610$17.90$28.8Kfiling
2026-09-182026-09-180Brumm Joshua TDirector, Chief Executive OfficerOpen market sale7,837$16.71$131Kfiling
2026-09-182026-09-180McNeill JonathanPresident and COOOpen market sale3,839$16.71$64.1Kfiling
2026-09-182026-09-162Scalzo Richard WilliamChief Financial OfficerOpen market sale568$17.90$10.2Kfiling
2026-09-182026-09-162Im Ellie EunkyungChief Medical OfficerOpen market sale623$17.90$11.2Kfiling
2026-09-182026-09-162McNeill JonathanPresident and COOOpen market sale731$17.90$13.1Kfiling
2026-09-182026-09-162Pinkas JanChief Scientific OfficerOpen market sale658$17.90$11.8Kfiling
2026-09-182026-09-162Lynch RyanSee RemarksOpen market sale240$17.90$4.3Kfiling
2026-07-202026-07-164Harwin Peter EvanDirector, 10% OwnerOpen market purchase525,897$14.50$7.6Mfiling
2026-07-202026-07-164Harwin Peter EvanDirector, 10% OwnerOpen market purchase853,450$14.50$12.4Mfiling

Source: U.S. Securities and Exchange Commission, EDGAR